A breakthrough on cancer therapy by inhibition of negative immune regulation: nobel prize in physiology or medicine 2018

dc.contributor.author	Soren, Karuna
dc.contributor.author	Kabiraj, Ashutosh
dc.contributor.author	Goswami, Prittam
dc.contributor.author	Banerjee, Aparna
dc.contributor.author	Bandopadhyay, Rajib
dc.date.accessioned	2023-05-16T14:52:49Z
dc.date.available	2023-05-16T14:52:49Z
dc.date.issued	2020
dc.identifier.uri	http://repositorio.ucm.cl/handle/ucm/4781
dc.description.abstract	James P. Allison from the MD Anderson Cancer Center, University of Texas, and Tasuku Honjo from Kyoto university were jointly awarded the prestigious Nobel Prize in Physiology/Medicine 2018. Their therapeutic research is on the inhibition of CTLA-4 and PD-1, two proteins which act as a blockade and prevent the immune system from attacking tumor cells.	es_CL
dc.language.iso	en	es_CL
dc.rights	Atribución-NoComercial-SinDerivadas 3.0 Chile	*
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/3.0/cl/	*
dc.source	National Academy Science Letters, 43(7), 681-685	es_CL
dc.subject	Cancer therapy	es_CL
dc.subject	Negative immune regulation	es_CL
dc.subject	Nobel prize	es_CL
dc.subject	Physiology/medicine	es_CL
dc.title	A breakthrough on cancer therapy by inhibition of negative immune regulation: nobel prize in physiology or medicine 2018	es_CL
dc.type	Article	es_CL
dc.ucm.indexacion	Scopus	es_CL
dc.ucm.indexacion	Isi	es_CL
dc.ucm.uri	sibib2.ucm.cl:2048/login?url=https://link.springer.com/article/10.1007/s40009-020-00940-0	es_CL
dc.ucm.doi	doi.org/10.1007/s40009-020-00940-0	es_CL

Ficheros en la publicación

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a esta publicación.

Excepto si se señala otra cosa, la licencia de la publicación se describe como Atribución-NoComercial-SinDerivadas 3.0 Chile